- PTLA has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $21.0 million.
- PTLA has traded 4,701 shares today.
- PTLA is trading at a new lifetime high.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in PTLA with the Ticky from Trade-Ideas. See the FREE profile for PTLA NOW at Trade-Ideas More details on PTLA: Portola Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapeutics for patients in the areas of thrombosis, other hematologic disorders, and inflammation. Currently there are 3 analysts that rate Portola Pharmaceuticals a buy, no analysts rate it a sell, and none rate it a hold. The average volume for Portola Pharmaceuticals has been 361,900 shares per day over the past 30 days. Portola has a market cap of $2.3 billion and is part of the health care sector and drugs industry. The stock has a beta of 0.74 and a short float of 9.7% with 6.22 days to cover. Shares are up 57.5% year-to-date as of the close of trading on Thursday. EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.